Unlock stock picks and a broker-level newsfeed that powers Wall Street.
1.9900
-0.0220
(-1.09%)
At close: April 4 at 8:06:05 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in SEK | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 4 |
| Avg. Estimate | 54.96M | 70.94M | 295.22M | 475.98M |
| Low Estimate | 50.94M | 65.9M | 224.93M | 429.53M |
| High Estimate | 62M | 81M | 412M | 523.31M |
| Year Ago Sales | 56M | 34.3M | 171.32M | 295.22M |
| Sales Growth (year/est) | -1.85% | 106.83% | 72.33% | 61.23% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 24H.F | -- | -- | -- | -- |
| S&P 500 | 6.59% | 6.64% | 9.81% | 16.08% |
Related Tickers
FARON.HE Faron Pharmaceuticals Oy
2.4300
-2.61%
AURA Aura Biosciences, Inc.
5.43
-4.90%
TECX Tectonic Therapeutic, Inc.
15.62
-6.30%
QTTB Q32 Bio Inc.
1.6400
+2.50%
UNCY Unicycive Therapeutics, Inc.
0.5159
-12.56%
TSHA Taysha Gene Therapies, Inc.
1.2200
-3.17%
OCUL Ocular Therapeutix, Inc.
6.36
-9.21%
RCKT Rocket Pharmaceuticals, Inc.
5.12
-7.91%
ALNY Alnylam Pharmaceuticals, Inc.
235.74
-10.08%
EWTX Edgewise Therapeutics, Inc.
11.51
-15.24%